Skip to main content
Clinical Trials/ISRCTN35317141
ISRCTN35317141
Completed
未知

Donor human milk versus preterm formula as a substitute for mothers' own milk for feeding very low birth weight infants

The Hospital for Sick Children0 sites363 target enrollmentAugust 10, 2010

Overview

Phase
未知
Intervention
Not specified
Conditions
eurodevelopmental outcomes
Sponsor
The Hospital for Sick Children
Enrollment
363
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

  1. 2014 protocol in: http://www.ncbi.nlm.nih.gov/pubmed/24884424 2. 2016 results in: http://www.ncbi.nlm.nih.gov/pubmed/27825008 3. 2018 results in: http://www.ncbi.nlm.nih.gov/pubmed/29546315 4. 2019 results in: https://www.ncbi.nlm.nih.gov/pubmed/31536118 (added 20/09/2019) 5. 2019 results in: https://www.ncbi.nlm.nih.gov/pubmed/31599955 (added 11/10/2019) 6. 2020 follow up results in https://pubmed.ncbi.nlm.nih.gov/31599955/ (added 10/08/2020)
Registry
who.int
Start Date
August 10, 2010
End Date
July 17, 2015
Last Updated
5 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Day 1 to 4 of life
  • 2\. Less than 1500 g birth weight
  • 3\. Enteral feeding is expected to be initiated in the first 7 days of life

Exclusion Criteria

  • 1\. Infants with serious congenital or chromosomal anomalies that may contribute to serious developmental outcome
  • 2\. Asphyxia (hypoxia or ischaemia) as defined by all of:
  • 2\.1\. Severe metabolic or mixed acidaemia (pH less than 7\.00 or base deficit less than \-16\) on an umbilical cord arterial blood sample or neonatal blood gas within first hour of life
  • 2\.2\. Apgar score of 0 \- 3 for greater than 5 minutes
  • 2\.3\. Multi\-organ system dysfunction within 72 hours of birth
  • 3\. Enrolment in any other clinical study affecting nutritional management during the feeding intervention
  • 4\. Reasonable potential that the infant will be transferred to a Neonatal Intensive Care Unit (NICU) or Level II NICU where the study protocol will not be continued

Outcomes

Primary Outcomes

Not specified

Similar Trials